Taotao Wang

1.6k total citations
75 papers, 1.2k citations indexed

About

Taotao Wang is a scholar working on Infectious Diseases, Pharmacology and Epidemiology. According to data from OpenAlex, Taotao Wang has authored 75 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Infectious Diseases, 23 papers in Pharmacology and 21 papers in Epidemiology. Recurrent topics in Taotao Wang's work include Antibiotics Pharmacokinetics and Efficacy (22 papers), Antimicrobial Resistance in Staphylococcus (15 papers) and Antifungal resistance and susceptibility (15 papers). Taotao Wang is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (22 papers), Antimicrobial Resistance in Staphylococcus (15 papers) and Antifungal resistance and susceptibility (15 papers). Taotao Wang collaborates with scholars based in China, United States and United Kingdom. Taotao Wang's co-authors include Yalin Dong, Dongxu Wang, Jiao Xie, Frank Qian, Haiyan Dong, Jianfeng Xing, Yan Wang, Yijun Wang, Qiang Gao and Song Xia and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Scientific Reports and Molecules.

In The Last Decade

Taotao Wang

68 papers receiving 1.2k citations

Peers

Countries citing papers authored by Taotao Wang

Since Specialization

Citations

This map shows the geographic impact of Taotao Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taotao Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taotao Wang more than expected).

Fields of papers citing papers by Taotao Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taotao Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taotao Wang. The network helps show where Taotao Wang may publish in the future.

Co-authorship network of co-authors of Taotao Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Taotao Wang. A scholar is included among the top collaborators of Taotao Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taotao Wang. Taotao Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A new perspective on antimicrobial therapeutic drug monitoring: Surface-enhanced Raman spectroscopy 2025 ·Talanta ·(unknown), Wei Yu, Jian‐Hui Lan, (unknown), Jiaojiao Chen, Shidi Zhao, Taotao Wang, Yalin Dong	1
2	Pharmacokinetics/Pharmacodynamics and Therapeutic Drug Monitoring of Ceftazidime/Avibactam in Patients With Gram‐Negative Bacterial Infections 2025 ·Journal of Clinical Pharmacy and Therapeutics ·(unknown), Dan Sun, Ying Zhang, (unknown), Taotao Wang	0
3	Mechanism and marker of voriconazole–induced liver injury: insights from a quantitative systems toxicology approach 2025 ·Regulatory Toxicology and Pharmacology ·Qian Du, Yulan Qiu, Luting Yang, (unknown), (unknown), Jiaojiao Chen, (unknown), Jinyao Sun, Taotao Wang, Siying Chen, Yalin Dong	0
4	A discovery in traditional Chinese medicine compatibility: Cinnabaris suppresses the Strychni Semen-induced neurotoxicity in Shang-Ke-Jie-Gu tablet 2024 ·Phytomedicine ·Na Han, Taotao Wang, Sheng Chang, Rong Gao, Yuanyuan Wen, Zhihui Liu, (unknown), Jianxiu Zhai, (unknown), (unknown), Jun Yin	0
5	Estimation of linezolid exposure in patients with hepatic impairment using machine learning based on a population pharmacokinetic model 2024 ·European Journal of Clinical Pharmacology ·(unknown), Lihong Chen, Xiaoliang Cheng, Houli Li, Taotao Wang, Yalin Dong, Haiyan Dong	2
6	Reprint of: Does two-step infusion improve the pharmacokinetics/pharmacodynamics target attainment of meropenem in critically Ill patients? 2024 ·Journal of Pharmaceutical Sciences ·Jiaojiao Chen, (unknown), Sihan Li, (unknown), (unknown), Shiqi Cheng, (unknown), (unknown), Tingting Yang, Dan Sun, Di Zhang, Yalin Dong, Taotao Wang	0
7	Metallo-β-lactamases immobilized by magnetic zeolitic imidazolate frameworks-8 for degradation of β-lactam antibiotics in an aqueous environment 2023 ·RSC Advances ·(unknown), (unknown), Shidi Zhao, (unknown), (unknown), Yalin Dong, Taotao Wang	0
8	Perfluorodecanoic acid promotes high-fat diet-triggered adiposity and hepatic lipid accumulation by modulating the NLRP3/caspase-1 pathway in male C57BL/6J mice 2023 ·Food and Chemical Toxicology ·Taotao Wang, Hong Xu, Canqing Yu, Yuanxin Guo, Huanan Guan, Dongxu Wang	7
9	Plasma trough concentration distribution and safety of high‐dose teicoplanin for patients with augmented renal clearance 2022 ·Journal of Clinical Pharmacy and Therapeutics ·Sasa Hu, Taotao Wang, Haisheng You, (unknown), Tao Zhang, Yalin Dong	2
10	Perfluorodecanoic acid promotes adipogenesis via NLRP3 inflammasome-mediated pathway in HepG2 and 3T3-L1 cells 2022 ·Food and Chemical Toxicology ·Taotao Wang, Hong Xu, Yu Guo, Zhanming Li, Hua Ye, (unknown), Yuanxin Guo, Dongxu Wang	6
11	Evaluation of the current guidelines for antibacterial therapy strategies in patients with cirrhosis or liver failure 2022 ·BMC Infectious Diseases ·(unknown), Dan Sun, Yan Wang, Qian Du, Ying Zhang, (unknown), (unknown), Tao Zhang, Lei Shi, (unknown), Yalin Dong, Taotao Wang	7
12	Cefoperazone/sulbactam therapeutic drug monitoring in patients with liver cirrhosis: Potential factors affecting the pharmacokinetic/pharmacodynamic target attainment 2019 ·Basic & Clinical Pharmacology & Toxicology ·(unknown), (unknown), Ying Li, Ying Zhang, Tao Zhang, Li Zhu, (unknown), (unknown), Taotao Wang	7
13	Risk factors for carbapenem-resistant Pseudomonas aeruginosa infection or colonization in a Chinese teaching hospital 2018 ·The Journal of Infection in Developing Countries ·Di Zhang, Kai Cui, Taotao Wang, Yuanyuan Shan, Haiyan Dong, Weiyi Feng, (unknown), Yalin Dong	9
14	Therapeutic drug monitoring and safety of voriconazole therapy in patients with Child–Pugh class B and C cirrhosis: A multicenter study 2018 ·International Journal of Infectious Diseases ·Taotao Wang, Miao Yan, Dan Tang, Ling Xue, Tao Zhang, (unknown), Li Zhu, Xinggang Wang, Yalin Dong	39
15	A strategy for designing voriconazole dosage regimens to prevent invasive pulmonary aspergillosis based on a cellular pharmacokinetics/pharmacodynamics model 2018 ·Journal of Translational Medicine ·Taotao Wang, Tao Zhang, (unknown), Ying Li, Lu Chen, Qianting Yang, Haiyan Dong, Jin’e Lei, Limei Chen, Yalin Dong	5
16	Type 2 diabetes mellitus is associated with increased risks of sarcopenia and pre-sarcopenia in Chinese elderly 2016 ·Scientific Reports ·Taotao Wang, Xiao Feng, Jingjing Zhou, (unknown), Song Xia, Qing Wei, Xu Hu, Ran Tao, Lei Li, Frank Qian, Li Yu	168
17	Pharmacokinetic/pharmacodynamic evaluation of linezolid for the treatment of staphylococcal infections in critically ill patients 2016 ·International Journal of Antimicrobial Agents ·Haiyan Dong, Jiao Xie, Taotao Wang, Lihong Chen, Xiaoyan Zeng, Jinyao Sun, Xue Wang, Yalin Dong	26
18	Modeling and forecasting Acinetobacter baumannii resistance to set appropriate use of cefoperazone-sulbactam: Results from trend analysis of antimicrobial consumption and development of resistance in a tertiary care hospital 2015 ·American Journal of Infection Control ·Jiao Xie, Yan Wang, Xiaowei Zheng, Qianting Yang, Taotao Wang, (unknown), Jianfeng Xing, Yalin Dong	5
19	Efficacy and safety of voriconazole and CYP2C19 polymorphism for optimised dosage regimens in patients with invasive fungal infections 2014 ·International Journal of Antimicrobial Agents ·Taotao Wang, (unknown), Jinyao Sun, Xiaoliang Cheng, Jiao Xie, Haiyan Dong, Limei Chen, Xue Wang, Jianfeng Xing, Yalin Dong	90
20	Proteomic analysis of the proteins that are associated with the resistance to paclitaxel in human breast cancer cells 2013 ·Molecular BioSystems ·Siying Chen, Qian Dong, Sasa Hu, Jiangxia Cai, Weipeng Zhang, (unknown), Taotao Wang, Jiao Xie, Hairong He, Jianfeng Xing, Jun Lü, Yalin Dong	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact